Article
Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Journal of diabetes and its complications - 1 Jan 2000
Orchard Trevor J, Backlund Jye-Yu C, Costacou Tina, Cleary Patricia, Lopes-Virella Maria, Levy Andrew P, Lachin John M
Abstract excerpt
AIMS/HYPOTHESIS: Haptoglobin(Hp) 2-2 genotype has been shown to increase coronary artery disease (CAD) risk in numerous type 2 diabetes studies but in only one type 1 diabetes cohort. We assessed the association of Hp2-2 with incident CAD over 26years of follow-up in 1303 Caucasian participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.